NCT00431522View on ClinicalTrials.gov

Valproic Acid Sodium Salt in Bipolar Disorder

PHASE4CompletedINTERVENTIONAL

Enrollment

58

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions

Bipolar Disorder

Interventions

DRUG

Valproic acid, sodium salt

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Istanbul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00431522 - Valproic Acid Sodium Salt in Bipolar Disorder | Biotech Hunter | Biotech Hunter